Clinical Evaluation of 368 Patients with Nasal Rosacea: Subtype Classification and Grading of Nasal Rosacea

Abstract

Background: The clinical features of nasal rosacea have not been described in detail. Objective: To describe the clinical features of nasal rosacea. Methods: 599 patients were classified into those with rosacea in both the nasal and extra-nasal areas (group A), localized nasal rosacea (group B) and rosacea without nasal involvement (group C). Results: The mixed subtype was more common in group A (n = 337) than in group C (n = 231). The severity score was higher in group A than in group C. Erythematotelangiectatic rosacea was the most common subtype in group B (n = 31) and was more common in group B than in group A. Rosacea mainly affected the lower half of the nose in group B, but affected the entire nose in group A. Conclusion: Nasal involvement may be an index of severe rosacea. Localized nasal rosacea is a separate spectrum with different clinical features.

Clinical features of Korean patients with rhinophyma

“…6,7 Lee et al 8 reported that 56 (9.3%) out of 599 rosacea patients had rhinophyma during the same period; similarly, in the present study, we diagnosed 39 (9.8%) patients with rhinophyma out of 382 rosacea patients, which was consistent with the previous observations of Lee et al in Asian patients 8 but lower than that observed in Western populations. 6,7 Lee et al 8 reported that 56 (9.3%) out of 599 rosacea patients had rhinophyma during the same period; similarly, in the present study, we diagnosed 39 (9.8%) patients with rhinophyma out of 382 rosacea patients, which was consistent with the previous observations of Lee et al in Asian patients 8 but lower than that observed in Western populations.…”

Clasificación y guía de tratamiento de rosácea

“…Para estos objetivos fueron analizados en forma crítica las distintas clasificaciones disponibles en la literatura y se redactaron las bases para conformar una guía de tratamiento útil al médico y al especialista considerando la bibliografía existente, con medicina basada en la evidencia, de las modalidades terapéuticas de le enfermedad [1][2][3][4][5][6][7][8][9][10][11][12][13] . Se dejaron fuera indicaciones no respaldadas por evidencia científica teniendo sí en consideración que las guías terapéuticas son dinámicas y sin dejar de plantear nuevas indicaciones avaladas científicamente en un futuro.…”

Prognosis of 234 rosacea patients according to clinical subtype: The significance of central facial erythema in the prognosis of rosacea

“…The 2002 NRS classification system defines the potential overlap of subtypes. Therefore, a rosacea patient may have two or more subtypes . The potential overlap of subtypes and disease progression among subtypes suggest that ETR, which is considered the initial phase of rosacea, may be accompanied by other subtypes such as PPR and PHY.…”

“…Therefore, a rosacea patient may have two or more subtypes. 2,10,11,13,14 The potential overlap of subtypes and disease progression among subtypes suggest that ETR, which is considered the initial phase of rosacea, may be accompanied by other subtypes such as PPR and PHY. According to rosacea diagnostic criteria, papulopustular eruption can occur with or without remarkable centrofacial erythema.…”